Procentra Solution
FDA Label NDC 21724-701

25 label sections · Submitted to the FDA by Independence Pharmaceuticals, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Independence Pharmaceuticals, Llc for the product Procentra (NDC 21724-701). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: abuse, misuse, and addiction, description, clinical pharmacology, pharmacokinetics, indications and usage, contraindications, abuse, misuse, and addiction, risks to patients with serious cardiac disease, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.